Table 2.
Clinical manifestations of PHN
| PHN (n = 27) | |
|---|---|
| Disease course (month), n (%) | |
| 1–3 | 13 (48.15%) |
| 4–6 | 4 (14.81%) |
| 7–12 | 6 (22.22%) |
| > 12 | 4 (14.81%) |
| Location of lesion, n (%) | |
| Face (Trigeminal nerve region) | 1 (3.70%) |
| Neck and upper limbs (Cervical nerve region) | 8 (29.63%) |
| Trunk (Thoracic nerve region) | 16 (59.26%) |
| Buttocks and lower limbs (Lumbar and Sacral nerves region) | 2 (7.41%) |
| Preherpetic pain, n (%) | 17 (62.96%) |
| Spontaneous pain, n (%) | 25 (92.59%) |
| Dynamic mechanical allodynia, n (%) | 16 (59.26%) |
| Sensory disturbance, n (%) | |
| Itching | 15 (55.56%) |
| Numbness | 13 (48.15%) |
| PHQ-9 (score), n (%) | |
| No depression (0–4) | 10 (37.04%) |
| mild (5–9) | 7 (25.93%) |
| moderate (10–14) | 4 (14.81%) |
| moderate-severe (15–19) | 4 (14.81%) |
| Severe (20–27) | 2 (7.41%) |
| GAD-7 (score), n (%) | |
| No anxiety (0–4) | 13 (48.15%) |
| Mild (5–9) | 12 (44.44%) |
| Moderate (10–13) | 0 (0%) |
| Moderate-severe (14–18) | 0 (0%) |
| Severe (19–21) | 2 (7.41%) |
| ISI (score), n (%) | |
| Insomnia without clinical significance (0–7) | 6 (22.22%) |
| Subclinical insomnia (8–14) | 16 (59.26%) |
| Clinical insomnia (moderate) (15–21) | 4 (14.81%) |
| Clinical insomnia (severe) (22–28) | 1 (3.70%) |
| Cold pain, n (%) | |
| Normal | 10 (37.04%) |
| Hypalgesia | 14 (51.85%) |
| Hyperpathia | 3 (11.11%) |
| Heat pain, n (%) | |
| Normal | 15 (55.56%) |
| Hypalgesia | 8 (29.63%) |
| Hyperpathia | 4 (14.81%) |
| Pain intensity (NRS 0–10), n (%) | |
| No pain (0) | 1 (3.70%) |
| Mild (1–3) | 12 (44.44%) |
| Moderate (4–6) | 6 (22.22%) |
| Severe (7–10) | 8 (29.63%) |
| Itching intensity (NRS 0–10), n (%) | |
| No itching (0) | 9 (33.33%) |
| Mild (1–3) | 12 (44.44%) |
| Moderate (4–6) | 5 (18.52%) |
| Severe (7–10) | 1 (3.70%) |
PHQ-9 Patient Health Questionnaire-9, GAD-7 Generalized Anxiety Disorder Screener-7, NRS numerical rating scale, ISI Insomnia Severity Index